SCHEMBL486247

SCHEMBL486247

CC(C)(O)C(C)(C)OB(O)c1cccs1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5050109 0.84 SMN1; SMN2 (0.32) SMN1; SMN2
SCHEMBL518218 0.81 DPP4 (0.41) SMN1; SMN2
SCHEMBL15168200 0.81 DPP4 (0.41) SMN1; SMN2
SCHEMBL25205631 0.76 SMN1; SMN2 (0.34) SMN1; SMN2
SCHEMBL19665034 0.75
SCHEMBL6607651 0.75 ERN1 (0.38)
SCHEMBL14844555 0.74 CA12 (0.30)
SCHEMBL2354652 0.74
SCHEMBL3665973 0.74
SCHEMBL290242 0.72 HDAC6 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036730-A Gαq/11 protein inhibitor with purine skeleton, and preparation method and application thereof 中山大学 2026-05-15 CN claimed
CN-118085847-A Tetraphenyl ethylene molecular composite material for beta-amyloid imaging and photodynamic oxidation 北京化工大学 2024-05-28 CN claimed
CN-115232145-B AIE type organic photosensitizer and synthetic method and application thereof 象山县第一人民医院医疗健康集团 2023-11-24 CN claimed
CN-112086564-A Passivating agent and passivation method thereof and method for preparing semiconductor film 杭州纤纳光电科技有限公司 2020-12-15 CN claimed
CN-109096159-B Star-shaped fluorescent molecule and preparation method and application thereof 华南协同创新研究院 2020-08-25 CN claimed
CN-111435705-A Repairing agent and repairing method thereof and method for preparing photoelectric film 杭州纤纳光电科技有限公司 2020-07-21 CN claimed
CN-110937967-A Bicyclopenteno [ cd, lm ] perylene derivative and preparation method and application thereof 杭州奥得科技有限公司 2020-03-31 CN claimed
CN-115943145-B Pyrazolopyrimidine compounds as ATR kinase inhibitors BEIJING TIDE PHARMACEUTICAL CO.,LTD. (CN) 2026-05-26 CN disclosed
CN-122036730-A Gαq/11 protein inhibitor with purine skeleton, and preparation method and application thereof 中山大学 2026-05-15 CN disclosed
US-12595263-B2 Pyrazolopyrimidine compound used as ATR kinase inhibitor BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) 2026-04-07 US disclosed
US-20250282615-A1 HYDROGEN PEROXIDE PRODUCTION METHOD INTERNATIONAL FRONTIER TECHNOLOGY LABORATORY, INC. (JP) 2025-09-11 US disclosed
US-20250282616-A1 HYDROGEN PEROXIDE PRODUCTION METHOD INTERNATIONAL FRONTIER TECHNOLOGY LABORATORY, INC. (JP) 2025-09-11 US disclosed
US-20250282617-A1 HYDROGEN PEROXIDE PRODUCTION METHOD INTERNATIONAL FRONTIER TECHNOLOGY LABORATORY, INC. (JP) 2025-09-11 US disclosed
WO-2010115767-A1 PYRROLOPYRROLE DERIVATIVES, THEIR MANUFACTURE AND USE AS SEMICONDUCTORS BASF SE (DE) 2010-10-14 WO disclosed
WO-2010108873-A1 DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES BASF SE (DE) 2010-09-30 WO disclosed
EP-2209788-A2 PYRROLOPYRROLE DERIVATIVES, THEIR MANUFACTURE AND USE BASF SE (DE) 2010-07-28 EP disclosed
WO-2010060160-A1 NOVEL COMPOUNDS, DERIVATIVES THEREOF AND THEIR USE IN HETEROJUNCTION DEVICES THE UNIVERSITY OF MELBOURNE (AU) 2010-06-03 WO disclosed
WO-2010049323-A1 DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES BASF SE (DE) 2010-05-06 WO disclosed
WO-2010049321-A1 DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC FIELD EFFECT TRANSISTORS BASF SE (DE) 2010-05-06 WO disclosed
WO-2009047104-A2 PYRROLOPYRROLE DERIVATIVES, THEIR MANUFACTURE AND USE BASF SE (CH) 2009-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595263-B2 Pyrazolopyrimidine compound used as ATR kinase inhibitor ATR, CHEK1, ATRIP SMN1; SMN2 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.